Chemotherapy is an important treatment for esophageal cancer, especially for patients with advanced esophageal cancer. It is mainly targeted at patients with advanced esophageal cancer, those who cannot undergo surgical treatment, those who are insensitive to radiotherapy, those who may have residual cancer tissue during surgery or those who are suspected of incomplete lymphatic clearance. The most commonly used drugs are bleomycin
(B)
, mitomycin
()
, doxorubicin
()
,
-
Fluorouracil
(-)
, methotrexate
()
etc.
Chemotherapy is generally used as an adjuvant treatment for esophageal cancer, and its role is divided into two parts: preoperative chemotherapy and postoperative chemotherapy.
Preoperative chemotherapy can reduce edema of tissues around esophageal cancer lesions, shrink tumors and reduce adhesions;
increase the chance of surgical resection or reduce the scope of surgical resection, which is conducive to radical surgery;
effective It can effectively kill micro-metastatic lesions that may exist in distant parts of the body, thereby reducing the probability of recurrence and metastasis;
avoiding the accelerated spread of cancer cells due to surgery and improving the survival rate.
Postoperative chemotherapy can kill distant metastatic cancer lesions, kill cancer cells or subclinical cancer cells that may be present in the blood, reduce the residual cancer in the body after surgery, improve the cure rate, thereby improving the patient's survival rate and Quality of Life.
Doctors often use combination chemotherapy when using chemotherapy. The common combination chemotherapy regimen is a combination of
and B
. Most of the effective rates exceed %
, and the remission period is
months. about. Combination chemotherapy is not only used for the treatment of intermediate and advanced esophageal cancer, but also for comprehensive treatment with surgery and radiotherapy. Currently, commonly used clinical combination chemotherapy regimens include -B
, B-
, --B
and ---
.
The chemotherapy plan for esophageal cancer should be based on the principle of individualization and based on the characteristics of the patient's local lesions and systemic conditions. Various treatment methods should be used rationally, not only to achieve radical cure, but also to consider the quality of life.
The latest research result patent is: Application (
Patent)
No.:.
. The present invention provides a product based on ()-
Ginsenoside R< br/>As an anti-cancer auxiliary drug with active ingredients and its application, the drug has the functions of enhancing the efficacy of anti-cancer drugs, reducing the toxicity of anti-cancer drugs, preventing and treating leukopenia caused by radiotherapy and chemotherapy, and enhancing the body's immune function. It can be used for the treatment of cancer. Adjuvant treatment.
Taking ginsenoside R during chemotherapy can increase the patient's appetite, return the number of platelets, and white blood cells to normal, and rarely cause adverse symptoms such as nausea and vomiting. It also has good effects such as pain relief and pain relief, improving the patient's quality of life. , so that the patient always maintains normal physical strength and successfully completes various treatments.
Zhu Junrong, Sun Jianguo and others studied the effect of ginsenoside R
on the proliferation and apoptosis of estrogen-dependent human breast cancer cells
. The results showed that
the growth of cells was inhibited by R
in a dose-dependent and time-dependent manner, and the half-inhibitory concentration was. &;/;
Optical microscopy showed that
cells After the action of R
, it showed obvious morphological changes of apoptosis;
Flow cytometry test confirmed that R
can induce
apoptosis within a certain concentration range, which will The cell cycle is arrested in the
phase and increases the expression of -
. This shows that R can inhibit cell proliferation and induce apoptosis, and is effective in breast cancer.
Ginsenoside R
also has good safety. Gao Feng and others from Jilin Ginseng Research Institute have confirmed through experiments that ginsenoside R
has an effect on the nervous system, respiratory system, There is no obvious effect on the cardiovascular system, which is significantly different from other anti-cancer chemotherapy drugs.
Because of its high efficiency and low toxicity, ginsenoside R
can kill tumor cells without damaging normal cells, so it is called a
cancer cell sniper
. At the same time, it is also an immune cell activator. It can activate the function of immune cells and use the body's own immune system to eliminate cancer cells, which is beneficial to the patient's recovery. (
The main functional ingredient of Jinxing Capsule
is ginsenoside R
, which has been approved for marketing. It uses internationally advanced patented technology to achieve industrialized production. Each capsule contains ginsenoside R.
Up to
many milligrams)
.
Ginsenoside R
【Applicable】
For patients who have just been diagnosed with cancer but it is difficult to determine a specific treatment plan, taking it can control the development of the disease and prevent tumor metastasis and spread. ;
, Taking it by patients before surgery can shrink the tumor, reduce the scope of surgery, and improve the success rate of surgery;
, Taking it by patients after surgery can eliminate remaining cancer cells and prevent recurrence. , transfer, and at the same time can accelerate incision healing, anti-inflammatory and analgesic, prevent and treat infection, and prevent complications;
, patients undergoing radiotherapy and chemotherapy can eliminate toxic side effects, enhance drug sensitivity, and improve Efficacy;
For patients with acute, severe, or late-stage cancer who are relatively weak, taking ginsenoside R
can quickly improve their immune function, enhance their anti-cancer ability, improve their quality of life, and extend their life span. ;
For patients in the recovery period of cancer, taking it regularly can effectively eliminate residual tumor cells and microscopic lesions in the body, enhance physical fitness, consolidate curative effect, and prevent recurrence and metastasis.
Ginsenoside r
Manufacturer Consultant Hu
Hour consultation hotline: (
Consultant Hu)
For more cancer rehabilitation consultation contact
:
, You can also directly add WeChat consultation through your mobile phone number
< Nr">
Chemotherapy Treatment for Esophageal Cancer